Registry-based randomised clinical trials: a remedy for evidence-based diabetes care?

This narrative review describes a new approach to navigation in a challenging landscape of clinical drug development in diabetes. Successful outcome studies in recent years have led to new indications and guidelines in type 2 diabetes, yet the number of clinical trials in diabetes is now declining....

Descripción completa

Detalles Bibliográficos
Autores principales: Eriksson, Jan W., Eliasson, Björn, Bennet, Louise, Sundström, Johan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2022
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9334551/
https://www.ncbi.nlm.nih.gov/pubmed/35902386
http://dx.doi.org/10.1007/s00125-022-05762-x

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9334551/
https://www.ncbi.nlm.nih.gov/pubmed/35902386
http://dx.doi.org/10.1007/s00125-022-05762-x

Ejemplares similares